These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 23841824)
1. Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder. Kim SH; Oh SA; Oh SJ Int J Urol; 2014 Feb; 21(2):179-83. PubMed ID: 23841824 [TBL] [Abstract][Full Text] [Related]
2. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. Kim SH; Kim TB; Kim SW; Oh SJ J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103 [TBL] [Abstract][Full Text] [Related]
3. Editorial comment to Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder. Furuta A; Suzuki Y Int J Urol; 2014 Feb; 21(2):183-4. PubMed ID: 23841883 [No Abstract] [Full Text] [Related]
4. Validation of voiding diary for stratification of bladder pain syndrome according to the presence/absence of cystoscopic abnormalities: a two-centre prospective study. Boudry G; Labat JJ; Riant T; Le Normand L; Manunta A; Bensalah K; Rigaud J BJU Int; 2013 Jul; 112(2):E164-8. PubMed ID: 23795793 [TBL] [Abstract][Full Text] [Related]
6. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Dell JR; Mokrzycki ML; Jayne CJ Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):105-9. PubMed ID: 19409685 [TBL] [Abstract][Full Text] [Related]
7. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis. Lai HH; Vetter J; Jain S; Gereau RW; Andriole GL J Urol; 2014 Dec; 192(6):1679-85. PubMed ID: 24907443 [TBL] [Abstract][Full Text] [Related]
8. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens. Lai MC; Kuo YC; Kuo HC Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498 [TBL] [Abstract][Full Text] [Related]
9. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? Gamper M; Regauer S; Welter J; Eberhard J; Viereck V J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361 [TBL] [Abstract][Full Text] [Related]
10. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder. Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264 [TBL] [Abstract][Full Text] [Related]
11. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history. Seth A; Teichman JM J Urol; 2008 Nov; 180(5):2029-33. PubMed ID: 18804240 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm. Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040 [TBL] [Abstract][Full Text] [Related]
13. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. Liu HT; Tyagi P; Chancellor MB; Kuo HC BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258 [TBL] [Abstract][Full Text] [Related]
14. Women overestimate daytime urinary frequency: the importance of the bladder diary. Stav K; Dwyer PL; Rosamilia A J Urol; 2009 May; 181(5):2176-80. PubMed ID: 19296975 [TBL] [Abstract][Full Text] [Related]
15. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Brown JS; McNaughton KS; Wyman JF; Burgio KL; Harkaway R; Bergner D; Altman DS; Kaufman J; Kaufman K; Girman CJ Urology; 2003 Apr; 61(4):802-9. PubMed ID: 12670569 [TBL] [Abstract][Full Text] [Related]
16. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis. Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961 [TBL] [Abstract][Full Text] [Related]
18. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis. Kuo HC Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491 [TBL] [Abstract][Full Text] [Related]
19. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. Humphrey L; Arbuckle R; Moldwin R; Nordling J; van de Merwe JP; Meunier J; Crook T; Abraham L Eur Urol; 2012 Feb; 61(2):271-9. PubMed ID: 22050826 [TBL] [Abstract][Full Text] [Related]
20. The overlap of interstitial cystitis/painful bladder syndrome and overactive bladder. Chung MK; Butrick CW; Chung CW JSLS; 2010; 14(1):83-90. PubMed ID: 20412643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]